Tag: Cardiovascular disease

FDA Class 1 recall renews concern about historically problematic heart pumps

The US Food & Drug Administration (FDA) announced a Class 1 recall on Monday for Abbott/Thoratec Corp.’s HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due due to biological material buildup obstructing the devices. According to an April 16 CBS News report, surgeons first noticed problems with the…

Read More

By: Matt Danford
April 17, 2024
Share

Donor hearts denied more often to male, black male transplant candidates

Editor's Note New research shows transplant center teams are more to likely reject offers of donor hearts to black men and men than black women and white women, MedPage Today reported on March 25. “The cumulative probability of a donor heart being accepted by the transplant center team was most…

Read More

By: Matt Danford
March 28, 2024
Share

Air pollution tied to hospital admissions for heart disease

Editor's Note Data published February 21 in The BMJ points to air pollution as a factor in increased hospital admissions for major heart diseases.  According to the Global Burden of Disease study, exposure to fine particulate matter (PM2.5) accounts for 7.6% of total mortality and 4.2% of disability-adjusted life years…

Read More

By: Brita Belli
February 23, 2024
Share

Transcatheter therapy system becomes first to earn FDA approval for treating tricuspid regurgitation

Editor's Note Patients with severe cases of tricuspid regurgitation (in which a critical heart valve fails to close properly) now have a new treatment option thanks to the recent US Food and Drug Administration (FDA) approval of the ENVOQUE tricuspid valve replacement system, according to a February 2 press release…

Read More

By: Matt Danford
February 14, 2024
Share

Chronic conditions spike nationwide

Editor's Note Eight chronic conditions—arthritis, depression, diabetes, asthma, cancer, cardiovascular diseases (CVDs), chronic obstructive pulmonary disease (COPD), and chronic kidney disease (CKD)—continue to expand nationwide along with premature deaths from drugs, firearms, and more, according America’s Health Rankings 2023 Annual Report. Presented by the United Health Foundation in partnership with…

Read More

By: Matt Danford
December 22, 2023
Share

New calculator determines likelihood of developing cardiovascular disease

Editor's Note For the first time, researchers have designed a calculator that estimates a person’s risk for developing cardiovascular disease (CVD) over the next 30 years. The news was announced in a statement from the American Heart Association in the journal Circulation on November 10. 1 in 3 U.S. adults…

Read More

By: Brita Belli
November 10, 2023
Share

'Million Hearts Model' reduces likelihood of first-time heart attack, stroke

Editor's Note The Million Hearts Model program—an initiative to prevent one million heart attacks and strokes within 5 years—reduced the probability of a first-time myocardial infarction or stroke without significant changes in Medicare spending. The findings were published by JAMA Network on October 12. The Million Hearts Model paid healthcare…

Read More

By: Brita Belli
October 18, 2023
Share

Study shows link between death from heart disease and depression

Editor's Note A new study from researchers at the Centers for Disease Control and Prevention has found that adults with moderate to severe depressive symptoms have a higher risk of death from cardiovascular disease and ischemic heart disease compared to those without depressive symptoms. The investigative study, titled "Depressive Symptoms…

Read More

By: Brita Belli
October 12, 2023
Share

Does a ‘weekend warrior’ physical activity pattern prevent cardiovascular disease?

Editor's Note This study by researches at the Massachusetts General Hospital, Boston, and the Broad Institute of MIT and Harvard, Cambridge, Massachusetts, examines whether moderate to vigorous physical activity concentrated in 1 to 2 days of the week (ie, a “weekend warrior” pattern) confers similar cardiovascular benefits as more evenly…

Read More

By: Judy Mathias
July 20, 2023
Share

FDA: Class I recall of Quidel Triage Cardiac Panels

Editor's Note The Food and Drug Administration (FDA), on July 17, identified the recall by Quidel Cardiovascular Inc of its Quidel Triage Cardiac Panels as Class I, the most serious. The recall was initiated because of reports of inaccurate tests showing lower than expected troponin levels in samples. A falsely…

Read More

By: Judy Mathias
July 19, 2023
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat